Myelin oligodendrocyte glycoprotein (MOG) immunoglobulin G (IgG)–associated disease
(MOGAD) is increasingly recognized as a distinct nosological entity from aquaporin‐4 …

Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) and aquaporin-4 IgG
seropositive neuromyelitis optica spectrum disorder (AQP4-IgG+ NMOSD) are generally …

Neuromyelitis optica spectrum disorders and myelin oligodend... : Current Opinion in
Neurology Neuromyelitis optica spectrum disorders and myelin oligodendrocyte …

Abstract Purpose of Review Antibodies against myelin oligodendrocyte glycoprotein (MOG)
are associated with a unique acquired central nervous system demyelinating disease …

Introduction Myelin oligodendrocyte glycoprotein-immunoglobulin G associated disease
(MOGAD) is a clinical entity distinct from multiple sclerosis and aquaporin-4 (AQP4+)-IgG …

Neuromyelitis optica (NMO) spectrum disorder (NMOSD) is a relapsing inflammatory
disease of the CNS, characterized by the presence of serum aquaporin 4 (AQP4) …

Our understanding of demyelinating optic neuritis has substantially evolved over the past 2
decades. With advancements in serological testing, antibodies against myelin …

BACKGROUND—Myelin oligodendrocyte glycoprotein (MOG), a protein on the surface of
oligodendrocytes, was once considered as a potential antibody target in multiple sclerosis …

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
inflammatory demyelinating disease of the central nervous system (CNS) with the presence …

Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …